In early medical progress (CT I), the main goal is to deliver the necessary amounts of material rapidly and in reproducible good quality.6 The organization strategies to provide 70% of its maximum-quantity products through continuous manufacturing inside 8 decades. The FDA has become a solid advocate for steady manufacturing Considering that the l